Madrigal Pharmaceuticals
MDGL
MDGL
31 hedge funds and large institutions have $20.1M invested in Madrigal Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.48M | |
| 2 | +$5.21M | |
| 3 | +$1.67M | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$161K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
Top Sellers
| 1 | -$6.42M | |
| 2 | -$332K | |
| 3 | -$205K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$192K |
| 5 |
Goldman Sachs
New York
|
-$153K |